BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7039632)

  • 1. Intraperitoneal insulin in the diabetic continuous ambulatory peritoneal dialysis (CAPD) patient - nursing management.
    Adair CM
    AANNT J; 1982 Apr; 9(2):62-3. PubMed ID: 7039632
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes, intraperitoneal insulin, and CAPD.
    Cohen IM; Lee S
    Clin Exp Dial Apheresis; 1981; 5(3):269-75. PubMed ID: 7037250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous ambulatory peritoneal dialysis in diabetes mellitus. The risks and benefits of intraperitoneal insulin.
    Madden MA; Zimmerman SW; Simpson DP
    Am J Nephrol; 1982; 2(3):133-9. PubMed ID: 6758585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal insulin: new alternative for diabetic CAPD patients.
    Bandel-Walcer R; Myers C; Malgaonkar S; Lyman N
    AANNT J; 1982 Aug; 9(4):31-5. PubMed ID: 7049191
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration.
    Quellhorst E
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intraperitoneal insulin in continuous ambulatory peritoneal dialysis].
    Riambau E; Aubia J; Llorach I; Lloveras J; Masramón J; Orfila A; Llorach M
    Rev Clin Esp; 1982 Mar; 164(5):333-4. PubMed ID: 7048442
    [No Abstract]   [Full Text] [Related]  

  • 7. [Double-bag CAPD with intraperitoneal insulin. Satisfactory management of diabetes and its major complications in uremic patients].
    Bazzato G; Lucatello S; Coli U; Landini S; Fracasso A; Morachiello P; Fabbro A
    Minerva Nefrol; 1981; 28(3):345-52. PubMed ID: 7036017
    [No Abstract]   [Full Text] [Related]  

  • 8. Continuous ambulatory peritoneal dialysis (CAPD) in diabetics with end-stage renal disease.
    Amair P; Khanna R; Digenis G; Oreopoulos DG
    Int J Artif Organs; 1982 Mar; 5(2):81-2. PubMed ID: 7047411
    [No Abstract]   [Full Text] [Related]  

  • 9. Intraperitoneal insulin for control of glucose level in insulin dependent diabetic patients treated by CAPD.
    Rottembourg J; Balducci A; Baumelou A; Jacq D; Agrafiotis A; Slama G
    Proc Clin Dial Transplant Forum; 1980; 10():305-7. PubMed ID: 7050993
    [No Abstract]   [Full Text] [Related]  

  • 10. Intraperitoneal insulin during peritoneal dialysis for patients with diabetes and renal failure.
    Krothapalli R; Patel HS; Lacke C; Payne W; Knight TF; Senekjian HO; Weinman EJ
    South Med J; 1983 Apr; 76(4):512-4. PubMed ID: 6340216
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intraperitoneal insulin therapy combined with continuous ambulatory peritoneal dialysis (CAPD)].
    Nevalainen P; Lahtela J; Mustonen J; Pasternack A
    Duodecim; 1996; 112(2):89-94. PubMed ID: 10590611
    [No Abstract]   [Full Text] [Related]  

  • 12. [Permanent control of blood glucose in diabetic patients using continuous ambulatory peritoneal dialysis. Continuous insulin infusion by the intraperitoneal route].
    Martinand A; Belleville I; Cabanne JF; Chuet C; Morey W; Brun JM; Rifle G
    Presse Med; 1984 Jan; 13(3):165. PubMed ID: 6229747
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraperitoneal insulin in uraemic diabetics undergoing continuous ambulatory peritoneal dialysis.
    Balducci A; Slama G; Rottembourg J; Baumelou A; Delage A
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1021-3. PubMed ID: 6794746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal insulin in diabetic CAPD patients.
    Mactier RA; Khanna R
    Int J Artif Organs; 1988 Jan; 11(1):9-12. PubMed ID: 3283057
    [No Abstract]   [Full Text] [Related]  

  • 15. Intraperitoneal insulin with CAPD - an artificial pancreas.
    Flynn CT; Nanson JA
    Trans Am Soc Artif Intern Organs; 1979; 25():114-7. PubMed ID: 392876
    [No Abstract]   [Full Text] [Related]  

  • 16. Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease.
    Amair P; Khanna R; Leibel B; Pierratos A; Vas S; Meema E; Blair G; Chisolm L; Vas M; Zingg W; Digenis G; Oreopoulos D
    N Engl J Med; 1982 Mar; 306(11):625-30. PubMed ID: 7035945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal (125I) insulin absorption during intermittent and continuous peritoneal dialysis.
    Wideröe TE; Smeby LC; Berg KJ; Jörstad S; Svartås TM
    Kidney Int; 1983 Jan; 23(1):22-8. PubMed ID: 6339786
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucose, insulin and C-peptide kinetics during continuous ambulatory peritoneal dialysis.
    Wideröe TE; Smeby LC; Myking OL; Wessel-Aas T
    Proc Eur Dial Transplant Assoc; 1983; 20():195-200. PubMed ID: 6361735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential hazard of U 100 insulin syringes in diabetic on CAPD.
    Fisher J; Wilson JM; Walls J
    Lancet; 1983 Dec; 2(8363):1363. PubMed ID: 6139692
    [No Abstract]   [Full Text] [Related]  

  • 20. Intermediary metabolism and glycemic control in insulin-dependent diabetic uremic patients treated by continuous peritoneal dialysis.
    Spotti D; Slaviero G; La Rocca E; Cantaluppi A; Castelnovo C; Micossi P; Quartagno R; Melandri M; Pozza G; Ponticelli C
    Nephron; 1988; 49(3):219-22. PubMed ID: 3041295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.